Literature DB >> 29846796

The REM sleep circuit and how its impairment leads to REM sleep behavior disorder.

Alex Iranzo1,2,3.   

Abstract

REM sleep is characterized by rapid eye movements, desynchronized electroencephalographic activity, dreams and muscle paralysis that preclude the individual from acting out the action of dreams. REM sleep is generated and modulated by a complex and still poorly understood, neuronal network that involves multiple nuclei and neurotransmission systems. The key structures that generate REM sleep muscle paralysis are the subcoeruleus nucleus in the mesopontine tegmentum and the reticular formation of the ventral medial medulla. Using glutamatergic, GABAergic and glycinergic inputs, direct and indirect projections from these two areas inhibit the motoneurons of the spinal cord resulting in skeletal paralysis in REM sleep. Experimental studies in cats and rodents where the subcoeruleus nucleus and ventral medial medulla were impaired by electrolytic, pharmacological and genetic manipulations have repeatedly produced increased electromyography activity during REM sleep associated with abnormal motor behaviors (e.g., prominent twitching, attack-like behaviors). These animal models represent the pathophysiological substrate of REM sleep behavior disorder, a parasomnia in humans characterized by nightmares and abnormal vigorous behaviors (e.g., prominent jerking, shouting, kicking) linked to excessive phasic and/or tonic electromyographic activity in REM sleep. The extraordinary observation that a sleep disorder is often the first manifestation of a devastating neurodegenerative disease such as Parkinson disease carries important diagnostic implications and opens a window for neuroprotection. This review addresses the neuronal substrates of REM sleep generation and modulation and how its impairment may lead to REM sleep behavior disorder.

Entities:  

Keywords:  Parkinson disease; REM sleep; REM sleep behavior disorder; Subcoeruleus nucleus; Ventral medial medulla

Mesh:

Year:  2018        PMID: 29846796     DOI: 10.1007/s00441-018-2852-8

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  13 in total

1.  Brain atrophy pattern in de novo Parkinson's disease with probable RBD associated with cognitive impairment.

Authors:  Javier Oltra; Carme Uribe; Barbara Segura; Anna Campabadal; Anna Inguanzo; Gemma C Monté-Rubio; Jèssica Pardo; Maria J Marti; Yaroslau Compta; Francesc Valldeoriola; Carme Junque; Alex Iranzo
Journal:  NPJ Parkinsons Dis       Date:  2022-05-24

Review 2.  Sleep Issues in Parkinson's Disease and Their Management.

Authors:  José Rafael P Zuzuárregui; Emmanuel H During
Journal:  Neurotherapeutics       Date:  2020-10-07       Impact factor: 7.620

3.  Sex Differences in Patterns of Sleep Disorders Among Hospitalizations With Parkinson's Disease: 2004-2014 Nationwide Inpatient Sample.

Authors:  Hind A Beydoun; Sharmin Hossain; Shuyan Huang; May A Beydoun; Brook T Alemu; Shaker M Eid; Alan B Zonderman
Journal:  Psychosom Med       Date:  2021-06-01       Impact factor: 3.864

Review 4.  Contribution of the GABAergic System to Non-Motor Manifestations in Premotor and Early Stages of Parkinson's Disease.

Authors:  Ane Murueta-Goyena; Ane Andikoetxea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

5.  Impaired Phasic Discharge of Locus Coeruleus Neurons Based on Persistent High Tonic Discharge-A New Hypothesis With Potential Implications for Neurodegenerative Diseases.

Authors:  Kathrin Janitzky
Journal:  Front Neurol       Date:  2020-05-12       Impact factor: 4.003

6.  Abnormal Gray Matter Volume and Functional Connectivity in Parkinson's Disease with Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Xu Jiang; Zhuang Wu; Min Zhong; Bo Shen; Jun Zhu; Yang Pan; Jun Yan; Wenbin Zhang; Pingyi Xu; Chaoyong Xiao; Li Zhang
Journal:  Parkinsons Dis       Date:  2021-02-22

7.  Sleep Disturbances and Associated Factors in Drug-Naïve Patients with Parkinson's Disease.

Authors:  Min Zhong; Xu Jiang; Sha Zhu; Ruxin Gu; Yu Bai; Hong He; Yang Pan; Pingyi Xu; Jun Yan; Li Zhang
Journal:  Neuropsychiatr Dis Treat       Date:  2021-12-03       Impact factor: 2.570

8.  Validation of Visually Identified Muscle Potentials during Human Sleep Using High Frequency/Low Frequency Spectral Power Ratios.

Authors:  Mo H Modarres; Jonathan E Elliott; Kristianna B Weymann; Dennis Pleshakov; Donald L Bliwise; Miranda M Lim
Journal:  Sensors (Basel)       Date:  2021-12-22       Impact factor: 3.576

9.  Prevalence and Risk Factors for Minor Hallucinations in Patients with Parkinson's Disease.

Authors:  Min Zhong; Ruxin Gu; Sha Zhu; Yu Bai; Zhuang Wu; Xu Jiang; Bo Shen; Jun Zhu; Yang Pan; Jun Yan; Li Zhang
Journal:  Behav Neurol       Date:  2021-10-04       Impact factor: 3.342

10.  Disrupted functional connectivity in PD with probable RBD and its cognitive correlates.

Authors:  Javier Oltra; Anna Campabadal; Barbara Segura; Carme Uribe; Maria Jose Marti; Yaroslau Compta; Francesc Valldeoriola; Nuria Bargallo; Alex Iranzo; Carme Junque
Journal:  Sci Rep       Date:  2021-12-21       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.